Medtronic plc(MDT)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
MDT | 109.38 B | 21.01x | 13.70% | 13.93% | $4.07 | 10.65% | 0.55x | 3.30% | $106.33 | $73.31 |
STE | 20.44 B | 25.60x | 7.30% | 13.33% | $8.19 | 11.39% | 0.28x | 1.20% | $267.14 | $193.97 |
TRIB | 5.5 M | - | - | -85.36% | -$58.97 | - | - | 0.00% | $52.50 | $5.01 |
HBCN.IR | - | - | - | - | - | - | - | - | - | - |
Peer Valuation & Performance Analysis
Peer group analysis for Medtronic plc (MDT) compared to its primary competitors (including STE, TRIB, HBCN.IR) reveals distinct metrics. MDT trades at a valuation premium compared to its competitors, with a P/E ratio of 21.0x versus the peer average of 12.7x (representing a 65% premium). This indicates that the market expects superior growth or commands a quality premium for MDT. In terms of growth, MDT's revenue growth of 13.7% exceeds the peer average of 7.3%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 13.9% compared to the peer average of -36.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• MDT ranks #1 in P/E ratio, #1 in revenue growth, and #1 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $87.40 | $88.19 | $85.43 | $85.51 | 55,891,000 | -1.81% |
| 2026-10-06 | $87.97 | $88.50 | $86.45 | $87.09 | 52,133,800 | -1.00% |
| 2026-10-05 | $86.33 | $88.12 | $85.53 | $87.97 | 43,693,700 | +1.84% |
| 2026-10-02 | $86.55 | $87.94 | $85.59 | $86.38 | 35,364,700 | -0.07% |
| 2026-10-01 | $85.85 | $86.84 | $85.22 | $86.44 | 29,277,400 | +0.17% |
| 2026-09-30 | $86.57 | $87.42 | $86.20 | $86.29 | 26,614,100 | -0.92% |
| 2026-09-29 | $88.83 | $89.22 | $86.38 | $87.09 | 19,448,000 | -2.69% |
| 2026-09-28 | $88.32 | $89.53 | $87.52 | $89.50 | 22,548,000 | +0.97% |
| 2026-09-25 | $87.61 | $88.99 | $87.12 | $88.64 | 13,053,500 | +0.97% |
| 2026-09-24 | $89.01 | $89.55 | $87.74 | $87.79 | 10,961,500 | -0.88% |
| 2026-09-23 | $89.79 | $90.41 | $87.89 | $88.57 | 10,532,200 | -1.62% |
| 2026-09-22 | $91.76 | $91.92 | $89.81 | $90.03 | 14,064,200 | -1.07% |
| 2026-09-21 | $90.76 | $91.98 | $90.76 | $91.00 | 7,311,200 | -0.41% |
| 2026-09-18 | $91.53 | $92.27 | $91.29 | $91.38 | 15,446,300 | -0.69% |
| 2026-09-17 | $91.88 | $92.67 | $91.46 | $92.02 | 10,900,900 | +0.18% |
Explore More Analysis for MDT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.